Kalium-1,4,5,6-tetrahydro-4,6-dioxo-1,3,5-triazin-2-carboxylat
|
|
|
- CAS-Nr.
- 2207-75-2
- Bezeichnung:
- Kalium-1,4,5,6-tetrahydro-4,6-dioxo-1,3,5-triazin-2-carboxylat
- Englisch Name:
- OXONIC ACID POTASSIUM SALT
- Synonyma:
- OXO;OTERACIL POTASSIUM;NOX4;POTASSIUM OXONATE;Potassium otastat;oxonic acid potassium;kox;KOX-1;Anti-KOX-1;otassiuM oxonate
- CBNumber:
- CB9435346
- Summenformel:
- C4H2KN3O4
- Molgewicht:
- 195.17
- MOL-Datei:
- 2207-75-2.mol
|
Kalium-1,4,5,6-tetrahydro-4,6-dioxo-1,3,5-triazin-2-carboxylat Eigenschaften
- Schmelzpunkt:
- 300 °C(lit.)
- storage temp.
- Inert atmosphere,2-8°C
- Löslichkeit
- Aqueous Base (Slightly), Water (Slightly, Heated, Sonicated)
- Aggregatzustand
- Powder
- Farbe
- White
- Wasserlöslichkeit
- Soluble in hot water.
- CAS Datenbank
- 2207-75-2(CAS DataBase Reference)
Sicherheit
- Risiko- und Sicherheitserklärung
- Gefahreninformationscode (GHS)
| S-Sätze: |
24/25 |
|
|
| WGK Germany |
3 |
|
|
| RTECS-Nr. |
RR4580000 |
|
|
| HS Code |
29349990 |
|
|
| Bildanzeige (GHS) |
|
| Alarmwort |
Warnung |
| Gefahrenhinweise |
| Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
| H302 |
Gesundheitsschädlich bei Verschlucken. |
Akute Toxizität oral |
Kategorie 4 |
Warnung |
![GHS hazard pictograms]() src="/GHS07.jpg" width="20" height="20" /> |
P264, P270, P301+P312, P330, P501 |
| H315 |
Verursacht Hautreizungen. |
Hautreizung |
Kategorie 2 |
Warnung |
![GHS hazard pictograms]() src="/GHS07.jpg" width="20" height="20" /> |
P264, P280, P302+P352, P321,P332+P313, P362 |
| H319 |
Verursacht schwere Augenreizung. |
Schwere Augenreizung |
Kategorie 2 |
Warnung |
![GHS hazard pictograms]() src="/GHS07.jpg" width="20" height="20" /> |
P264, P280, P305+P351+P338,P337+P313P |
| H335 |
Kann die Atemwege reizen. |
Spezifische Zielorgan-Toxizität (einmalige Exposition) |
Kategorie 3 (Atemwegsreizung) |
Warnung |
![GHS hazard pictograms]() src="/GHS07.jpg" width="20" height="20" /> |
|
|
| Sicherheit |
| P261 |
Einatmen von Staub vermeiden. |
| P305+P351+P338 |
BEI KONTAKT MIT DEN AUGEN: Einige Minuten lang behutsam mit Wasser spülen. Eventuell vorhandene Kontaktlinsen nach Möglichkeit entfernen. Weiter spülen. |
|
Kalium-1,4,5,6-tetrahydro-4,6-dioxo-1,3,5-triazin-2-carboxylat Chemische Eigenschaften,Einsatz,Produktion Methoden
S-Sätze Betriebsanweisung:
S24/25:Berührung mit den Augen und der Haut vermeiden.
Beschreibung
Oxonic acid is a uricase inhibitor that prevents metabolism and excretion of uric acid and induces embryotoxicity and nephrotoxicity in rats. It is a component of S-1, a mixture containing a prodrug of the antitumor agent 5-fluorouracil (5-FU; ), that suppresses the gastrointestinal toxicity of 5-FU without inhibiting its antitumor activity in rats. Formulations containing oxonic acid have been used to treat gastric, pancreatic, lung, head, neck, and breast carcinomas.
Chemische Eigenschaften
Off-White Solid
Verwenden
Oxonic acid potassium salt is an inhibitor of uricase. The product from Sigma has been used for the inhibition of 5-fluorouracil-induced gastrointestinal toxicity without the loss of its antitumor activity in rats.It has also been used to induce hyperuricemia in rats; as it inhibits uric acid metabolism.
Kalium-1,4,5,6-tetrahydro-4,6-dioxo-1,3,5-triazin-2-carboxylat Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Kalium-1,4,5,6-tetrahydro-4,6-dioxo-1,3,5-triazin-2-carboxylat Anbieter Lieferant Produzent Hersteller Vertrieb Händler.
Global( 381)Lieferanten
2207-75-2(Kalium-1,4,5,6-tetrahydro-4,6-dioxo-1,3,5-triazin-2-carboxylat)Verwandte Suche:
- 1,4,5,6-tetrahydro-4,6-dioxo-s-triazine-2-carboxylicacid,potassiumsalt
- 5-azaoroticacid,potassiumsalt
- 4,6-Dihydroxy-1,3,5-triazine-2-carboxylic acid potassium salt, Allantoxanic acid
- （OXO）Oteracil potassium
- Potassium 4,6-dioxo-1H-1,3,5-triazine-2-carboxylate
- Potassium s-triazine-2,4-dione-6-carboxylate
- 1,4,5,6-Tetrahydro-4,6-dioxo-1,3,5-triazine-2-carboxylic acid potassium salt
- Allantoxanic acid potassium
- potassium 4,6-dioxo-1,4,5,6-tetrahydro-1,3,5-triazine-2-carboxylate
- Allantoxanic Acid Potassium Salt
Oxonic Acid Potassium Salt
Potassium Allantoxanate
Potassium 4,6-Dihydroxy-1,3,5-triazine-2-carboxylate
- POTASSIUMOXONATE/OTERACILPOTASSIUM
- Oteracil potassium(OXO)
- otassiuM oxonate
- Oxonic acid potassiuM salt 97%
- PotassiuM oxonate(OXO)
- Potassium oxonate
Oxonic acid potassium salt
- Anti-ZNF10, (N-terminal) antibody produced in rabbit
- Anti-NOX4 antibody produced in rabbit
- POTASSIUM 4,6-DIHYDROXY-1,3,5-TRIAZINE-2-CARBOXYLATE
- Potassium 1,4,5,6-tetrahydro-4,6-dioxo-1,3,5-triazine-2-carboxylate
- POTASSIUM ALLANTOXANATE
- OXONIC ACID POTASSIUM SALT
- kox
- potassiumazaorotate
- LABOTEST-BB LT00138090
- ALLANTOXANIC ACID POTASSIUM SALT
- 4,6-DIHYDROXY-1,3,5-TRIAZINE-2-CARBOXYLIC ACID, POTASSIUM SALT
- Oxonic acid, potassium salt, 97.50%
- KOX-1
- Anti-Kidney superoxide-producing NADPH oxidase
- Anti-KOX-1
- Anti-NADPH oxidase 4
- Anti-Renal NAD(P)H-oxidase
- OXONIC ACID POTASSIUM SALT 97.5%
- Oxonic acid potassium salt, >=99%
- 1，2，3，4-etetrahydro-2,4-dioxo-1,3,5-triazin-6-carboxylate
- Oxonic acid potassium salt (OXO)
- Potassium 2,6-dihydroxytriazinecarboxylate
- potassium 4,6-dioxo-1H-1,3,5-triazine-2-carboxylic acid
- 1,3,5-Triazine-2-carboxylic acid, 1,4,5,6-tetrahydro-4,6-dioxo-, potassium salt (1:1)
- PotassiumOxonate>
- Potassium Oxonate,>98%
- Hot selling Oteracil potassium
- Potassium Oxoxazine Impurity
- 4,6-dioxo-1H-1,3,5-triazine-2-carboxylate
- OXO
- POTASSIUM OXONATE
- OTERACIL POTASSIUM
- oxonic acid potassium
- NOX4
- Potassium otastat
- Oxygen oxazine acid potassium
- Potassium Oxonate, ≥ 98.0%
- 2207-75-2
- 2202-75-2
- 2204-75-2
- C4H2N3O4K
- C4H2KN3O4
